APO Research
Talk to an analyst

APO RESEARCH · REPORT

Rasagiline Tablet

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Rasagiline Tablet Market Outlook and Growth Opportunities 2026

27 December 2025193 pages

Choose your research edition.

Industry ResearchRasagiline Tablet Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Rasagiline Tablet Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Rasagiline Tablet Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Rasagiline Tablet Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Rasagiline Tablet Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Rasagiline Tablet market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Rasagiline Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Rasagiline Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Rasagiline Tablet is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Rasagiline Tablet market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Rasagiline Tablet market include Takeda Pharmaceutical, Teva Pharmaceutical, Sun Pharmaceutical, Sandoz, Mylan, Taj Pharma, Orchid Pharma, Natco Pharma and Lundbeck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Rasagiline Tablet market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Rasagiline Tablet and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Rasagiline Tablet sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Rasagiline Tablet market size, projected growth trends, production technologies, key applications, and end-use industries.

Rasagiline Tablet Segment by Company

Takeda Pharmaceutical

Teva Pharmaceutical

Sun Pharmaceutical

Sandoz

Mylan

Taj Pharma

Orchid Pharma

Natco Pharma

Lundbeck

Intas Pharmaceuticals

Apotex

Alkem Laboratories

Ajanta Pharma

Rasagiline Tablet Segment by Type

0.5 mg/Pcs

1 mg/Pcs

Rasagiline Tablet Segment by Application

40-65 Years Old

Under 40 Years Old

Above 65 Years Old

Rasagiline Tablet Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Rasagiline Tablet status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Rasagiline Tablet market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Rasagiline Tablet significant trends, drivers, influence factors in global and regions.

6. To analyze Rasagiline Tablet competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Rasagiline Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Rasagiline Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Rasagiline Tablet.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Rasagiline Tablet market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Rasagiline Tablet industry.

Chapter 3: Detailed analysis of Rasagiline Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Rasagiline Tablet in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Rasagiline Tablet in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Rasagiline Tablet Industry Trends Table 2. Rasagiline Tablet Industry Drivers Table 3. Rasagiline Tablet Industry Opportunities and Challenges Table 4. Rasagiline Tablet Industry Restraints Table 5. Global Rasagiline Tablet Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Rasagiline Tablet Revenue Share by Company (2021-2026) Table 7. Global Rasagiline Tablet Sales Volume by Company (Pcs) & (2021-2026) Table 8. Global Rasagiline Tablet Sales Volume Share by Company (2021-2026) Table 9. Global Rasagiline Tablet Average Price (US$/Pcs) of Company (2021-2026) Table 10. Global Rasagiline Tablet Company Ranking, (2024-2026) & (USD Million) Table 11. Global Rasagiline Tablet Key Company Manufacturing Base & Headquarters Table 12. Global Rasagiline Tablet Company, Product Type & Application Table 13. Global Rasagiline Tablet Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Rasagiline Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.5 mg/Pcs Table 18. Significant Companies of 1 mg/Pcs Table 19. Global Rasagiline Tablet Sales Volume by Type 2021 VS 2025 VS 2032 (Pcs) Table 20. Global Rasagiline Tablet Sales Volume by Type (2021-2026) & (Pcs) Table 21. Global Rasagiline Tablet Sales Volume by Type (2027-2032) & (Pcs) Table 22. Global Rasagiline Tablet Sales Volume Share by Type (2021-2026) Table 23. Global Rasagiline Tablet Sales Volume Share by Type (2027-2032) Table 24. Global Rasagiline Tablet Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Rasagiline Tablet Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Rasagiline Tablet Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Rasagiline Tablet Sales Value Share by Type (2021-2026) Table 28. Global Rasagiline Tablet Sales Value Share by Type (2027-2032) Table 29. Significant Companies of 40-65 Years Old Table 30. Significant Companies of Under 40 Years Old Table 31. Significant Companies of Above 65 Years Old Table 32. Global Rasagiline Tablet Sales Volume by Application 2021 VS 2025 VS 2032 (Pcs) Table 33. Global Rasagiline Tablet Sales Volume by Application (2021-2026) & (Pcs) Table 34. Global Rasagiline Tablet Sales Volume by Application (2027-2032) & (Pcs) Table 35. Global Rasagiline Tablet Sales Volume Share by Application (2021-2026) Table 36. Global Rasagiline Tablet Sales Volume Share by Application (2027-2032) Table 37. Global Rasagiline Tablet Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Rasagiline Tablet Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Rasagiline Tablet Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Rasagiline Tablet Sales Value Share by Application (2021-2026) Table 41. Global Rasagiline Tablet Sales Value Share by Application (2027-2032) Table 42. Global Rasagiline Tablet Sales by Region: 2021 VS 2025 VS 2032 (Pcs) Table 43. Global Rasagiline Tablet Sales by Region (2021-2026) & (Pcs) Table 44. Global Rasagiline Tablet Sales Market Share by Region (2021-2026) Table 45. Global Rasagiline Tablet Sales by Region (2027-2032) & (Pcs) Table 46. Global Rasagiline Tablet Sales Market Share by Region (2027-2032) Table 47. Global Rasagiline Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Rasagiline Tablet Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Rasagiline Tablet Sales Value Share by Region (2021-2026) Table 50. Global Rasagiline Tablet Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Rasagiline Tablet Sales Value Share by Region (2027-2032) Table 52. Global Rasagiline Tablet Market Average Price (US$/Pcs) by Region (2021-2026) Table 53. Global Rasagiline Tablet Market Average Price (US$/Pcs) by Region (2027-2032) Table 54. Global Rasagiline Tablet Sales by Country: 2021 VS 2025 VS 2032 (Pcs) Table 55. Global Rasagiline Tablet Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Rasagiline Tablet Sales by Country (2021-2026) & (Pcs) Table 57. Global Rasagiline Tablet Sales Market Share by Country (2021-2026) Table 58. Global Rasagiline Tablet Sales by Country (2027-2032) & (Pcs) Table 59. Global Rasagiline Tablet Sales Market Share by Country (2027-2032) Table 60. Global Rasagiline Tablet Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Rasagiline Tablet Sales Value Market Share by Country (2021-2026) Table 62. Global Rasagiline Tablet Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Rasagiline Tablet Sales Value Market Share by Country (2027-2032) Table 64. Takeda Pharmaceutical Company Information Table 65. Takeda Pharmaceutical Business Overview Table 66. Takeda Pharmaceutical Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 67. Takeda Pharmaceutical Rasagiline Tablet Product Portfolio Table 68. Takeda Pharmaceutical Recent Development Table 69. Teva Pharmaceutical Company Information Table 70. Teva Pharmaceutical Business Overview Table 71. Teva Pharmaceutical Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 72. Teva Pharmaceutical Rasagiline Tablet Product Portfolio Table 73. Teva Pharmaceutical Recent Development Table 74. Sun Pharmaceutical Company Information Table 75. Sun Pharmaceutical Business Overview Table 76. Sun Pharmaceutical Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Rasagiline Tablet Product Portfolio Table 78. Sun Pharmaceutical Recent Development Table 79. Sandoz Company Information Table 80. Sandoz Business Overview Table 81. Sandoz Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 82. Sandoz Rasagiline Tablet Product Portfolio Table 83. Sandoz Recent Development Table 84. Mylan Company Information Table 85. Mylan Business Overview Table 86. Mylan Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 87. Mylan Rasagiline Tablet Product Portfolio Table 88. Mylan Recent Development Table 89. Taj Pharma Company Information Table 90. Taj Pharma Business Overview Table 91. Taj Pharma Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 92. Taj Pharma Rasagiline Tablet Product Portfolio Table 93. Taj Pharma Recent Development Table 94. Orchid Pharma Company Information Table 95. Orchid Pharma Business Overview Table 96. Orchid Pharma Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 97. Orchid Pharma Rasagiline Tablet Product Portfolio Table 98. Orchid Pharma Recent Development Table 99. Natco Pharma Company Information Table 100. Natco Pharma Business Overview Table 101. Natco Pharma Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 102. Natco Pharma Rasagiline Tablet Product Portfolio Table 103. Natco Pharma Recent Development Table 104. Lundbeck Company Information Table 105. Lundbeck Business Overview Table 106. Lundbeck Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 107. Lundbeck Rasagiline Tablet Product Portfolio Table 108. Lundbeck Recent Development Table 109. Intas Pharmaceuticals Company Information Table 110. Intas Pharmaceuticals Business Overview Table 111. Intas Pharmaceuticals Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 112. Intas Pharmaceuticals Rasagiline Tablet Product Portfolio Table 113. Intas Pharmaceuticals Recent Development Table 114. Apotex Company Information Table 115. Apotex Business Overview Table 116. Apotex Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 117. Apotex Rasagiline Tablet Product Portfolio Table 118. Apotex Recent Development Table 119. Alkem Laboratories Company Information Table 120. Alkem Laboratories Business Overview Table 121. Alkem Laboratories Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 122. Alkem Laboratories Rasagiline Tablet Product Portfolio Table 123. Alkem Laboratories Recent Development Table 124. Ajanta Pharma Company Information Table 125. Ajanta Pharma Business Overview Table 126. Ajanta Pharma Rasagiline Tablet Sales (Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 127. Ajanta Pharma Rasagiline Tablet Product Portfolio Table 128. Ajanta Pharma Recent Development Table 129. Key Raw Materials Table 130. Raw Materials Key Suppliers Table 131. Rasagiline Tablet Distributors List Table 132. Rasagiline Tablet Customers List Table 133. Research Programs/Design for This Report Table 134. Authors List of This Report Table 135. Secondary Sources Table 136. Primary Sources List of Figures Figure 1. Rasagiline Tablet Product Image Figure 2. Global Rasagiline Tablet Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Rasagiline Tablet Sales Value (2021-2032) & (US$ Million) Figure 4. Global Rasagiline Tablet Sales (2021-2032) & (Pcs) Figure 5. Global Rasagiline Tablet Sales Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Rasagiline Tablet Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.5 mg/Pcs Image Figure 10. 1 mg/Pcs Image Figure 11. Global Rasagiline Tablet Sales Volume by Type (2021 VS 2025 VS 2032) & (Pcs) Figure 12. Global Rasagiline Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Rasagiline Tablet Sales Volume Share by Type (2021-2032) Figure 14. Global Rasagiline Tablet Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Rasagiline Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Rasagiline Tablet Sales Value Share by Type (2021-2032) Figure 17. 40-65 Years Old Image Figure 18. Under 40 Years Old Image Figure 19. Above 65 Years Old Image Figure 20. Global Rasagiline Tablet Sales Volume by Application (2021 VS 2025 VS 2032) & (Pcs) Figure 21. Global Rasagiline Tablet Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Rasagiline Tablet Sales Volume Share by Application (2021-2032) Figure 23. Global Rasagiline Tablet Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Rasagiline Tablet Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Rasagiline Tablet Sales Value Share by Application (2021-2032) Figure 26. Global Rasagiline Tablet Sales by Region: 2021 VS 2025 VS 2032 (Pcs) Figure 27. Global Rasagiline Tablet Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Rasagiline Tablet Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Rasagiline Tablet Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Rasagiline Tablet Sales Value (2021-2032) & (US$ Million) Figure 31. North America Rasagiline Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Rasagiline Tablet Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Rasagiline Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Rasagiline Tablet Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Rasagiline Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Rasagiline Tablet Sales Value (2021-2032) & (US$ Million) Figure 37. South America Rasagiline Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Rasagiline Tablet Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Rasagiline Tablet Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Rasagiline Tablet Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Rasagiline Tablet Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Rasagiline Tablet Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5 mg/Pcs
  • 1 mg/Pcs
Applications
  • 40-65 Years Old
  • Under 40 Years Old
  • Above 65 Years Old
Companies covered
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
  • Sun Pharmaceutical
  • Sandoz
  • Mylan
  • Taj Pharma
  • Orchid Pharma
  • Natco Pharma
  • Lundbeck
  • Intas Pharmaceuticals
  • Apotex
  • Alkem Laboratories
  • Ajanta Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Rasagiline Tablet Sales Value (2021-2032)
  4. 1.2.2 Global Rasagiline Tablet Sales Volume (2021-2032)
  5. 1.2.3 Global Rasagiline Tablet Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Rasagiline Tablet Market Dynamics
  1. 2.1 Rasagiline Tablet Industry Trends
  2. 2.2 Rasagiline Tablet Industry Drivers
  3. 2.3 Rasagiline Tablet Industry Opportunities and Challenges
  4. 2.4 Rasagiline Tablet Industry Restraints
3 Rasagiline Tablet Market by Company
  1. 3.1 Global Rasagiline Tablet Company Revenue Ranking in 2025
  2. 3.2 Global Rasagiline Tablet Revenue by Company (2021-2026)
  3. 3.3 Global Rasagiline Tablet Sales Volume by Company (2021-2026)
  4. 3.4 Global Rasagiline Tablet Average Price by Company (2021-2026)
  5. 3.5 Global Rasagiline Tablet Company Ranking (2024-2026)
  6. 3.6 Global Rasagiline Tablet Company Manufacturing Base and Headquarters
  7. 3.7 Global Rasagiline Tablet Company Product Type and Application
  8. 3.8 Global Rasagiline Tablet Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Rasagiline Tablet Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Rasagiline Tablet Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Rasagiline Tablet Market by Type
  1. 4.1 Rasagiline Tablet Type Introduction
  2. 4.1.1 0.5 mg/Pcs
  3. 4.1.2 1 mg/Pcs
  4. 4.2 Global Rasagiline Tablet Sales Volume by Type
  5. 4.2.1 Global Rasagiline Tablet Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Rasagiline Tablet Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Rasagiline Tablet Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Rasagiline Tablet Sales Value by Type
  9. 4.3.1 Global Rasagiline Tablet Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Rasagiline Tablet Sales Value by Type (2021-2032)
  11. 4.3.3 Global Rasagiline Tablet Sales Value Share by Type (2021-2032)
5 Rasagiline Tablet Market by Application
  1. 5.1 Rasagiline Tablet Application Introduction
  2. 5.1.1 40-65 Years Old
  3. 5.1.2 Under 40 Years Old
  4. 5.1.3 Above 65 Years Old
  5. 5.2 Global Rasagiline Tablet Sales Volume by Application
  6. 5.2.1 Global Rasagiline Tablet Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Rasagiline Tablet Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Rasagiline Tablet Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Rasagiline Tablet Sales Value by Application
  10. 5.3.1 Global Rasagiline Tablet Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Rasagiline Tablet Sales Value by Application (2021-2032)
  12. 5.3.3 Global Rasagiline Tablet Sales Value Share by Application (2021-2032)
6 Rasagiline Tablet Regional Sales and Value Analysis
  1. 6.1 Global Rasagiline Tablet Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Rasagiline Tablet Sales by Region (2021-2032)
  3. 6.2.1 Global Rasagiline Tablet Sales by Region: 2021-2026
  4. 6.2.2 Global Rasagiline Tablet Sales by Region (2027-2032)
  5. 6.3 Global Rasagiline Tablet Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Rasagiline Tablet Sales Value by Region (2021-2032)
  7. 6.4.1 Global Rasagiline Tablet Sales Value by Region: 2021-2026
  8. 6.4.2 Global Rasagiline Tablet Sales Value by Region (2027-2032)
  9. 6.5 Global Rasagiline Tablet Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Rasagiline Tablet Sales Value (2021-2032)
  12. 6.6.2 North America Rasagiline Tablet Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Rasagiline Tablet Sales Value (2021-2032)
  15. 6.7.2 Europe Rasagiline Tablet Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Rasagiline Tablet Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Rasagiline Tablet Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Rasagiline Tablet Sales Value (2021-2032)
  21. 6.9.2 South America Rasagiline Tablet Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Rasagiline Tablet Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Rasagiline Tablet Sales Value Share by Country, 2025 VS 2032
7 Rasagiline Tablet Country-level Sales and Value Analysis
  1. 7.1 Global Rasagiline Tablet Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Rasagiline Tablet Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Rasagiline Tablet Sales by Country (2021-2032)
  4. 7.3.1 Global Rasagiline Tablet Sales by Country (2021-2026)
  5. 7.3.2 Global Rasagiline Tablet Sales by Country (2027-2032)
  6. 7.4 Global Rasagiline Tablet Sales Value by Country (2021-2032)
  7. 7.4.1 Global Rasagiline Tablet Sales Value by Country (2021-2026)
  8. 7.4.2 Global Rasagiline Tablet Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Rasagiline Tablet Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Rasagiline Tablet Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Rasagiline Tablet Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda Pharmaceutical
  2. 8.1.1 Takeda Pharmaceutical Company Information
  3. 8.1.2 Takeda Pharmaceutical Business Overview
  4. 8.1.3 Takeda Pharmaceutical Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Pharmaceutical Rasagiline Tablet Product Portfolio
  6. 8.1.5 Takeda Pharmaceutical Recent Developments
  7. 8.2 Teva Pharmaceutical
  8. 8.2.1 Teva Pharmaceutical Company Information
  9. 8.2.2 Teva Pharmaceutical Business Overview
  10. 8.2.3 Teva Pharmaceutical Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Pharmaceutical Rasagiline Tablet Product Portfolio
  12. 8.2.5 Teva Pharmaceutical Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Rasagiline Tablet Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Rasagiline Tablet Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Mylan
  26. 8.5.1 Mylan Company Information
  27. 8.5.2 Mylan Business Overview
  28. 8.5.3 Mylan Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Mylan Rasagiline Tablet Product Portfolio
  30. 8.5.5 Mylan Recent Developments
  31. 8.6 Taj Pharma
  32. 8.6.1 Taj Pharma Company Information
  33. 8.6.2 Taj Pharma Business Overview
  34. 8.6.3 Taj Pharma Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Taj Pharma Rasagiline Tablet Product Portfolio
  36. 8.6.5 Taj Pharma Recent Developments
  37. 8.7 Orchid Pharma
  38. 8.7.1 Orchid Pharma Company Information
  39. 8.7.2 Orchid Pharma Business Overview
  40. 8.7.3 Orchid Pharma Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Orchid Pharma Rasagiline Tablet Product Portfolio
  42. 8.7.5 Orchid Pharma Recent Developments
  43. 8.8 Natco Pharma
  44. 8.8.1 Natco Pharma Company Information
  45. 8.8.2 Natco Pharma Business Overview
  46. 8.8.3 Natco Pharma Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Natco Pharma Rasagiline Tablet Product Portfolio
  48. 8.8.5 Natco Pharma Recent Developments
  49. 8.9 Lundbeck
  50. 8.9.1 Lundbeck Company Information
  51. 8.9.2 Lundbeck Business Overview
  52. 8.9.3 Lundbeck Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Lundbeck Rasagiline Tablet Product Portfolio
  54. 8.9.5 Lundbeck Recent Developments
  55. 8.10 Intas Pharmaceuticals
  56. 8.10.1 Intas Pharmaceuticals Company Information
  57. 8.10.2 Intas Pharmaceuticals Business Overview
  58. 8.10.3 Intas Pharmaceuticals Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Intas Pharmaceuticals Rasagiline Tablet Product Portfolio
  60. 8.10.5 Intas Pharmaceuticals Recent Developments
  61. 8.11 Apotex
  62. 8.11.1 Apotex Company Information
  63. 8.11.2 Apotex Business Overview
  64. 8.11.3 Apotex Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Apotex Rasagiline Tablet Product Portfolio
  66. 8.11.5 Apotex Recent Developments
  67. 8.12 Alkem Laboratories
  68. 8.12.1 Alkem Laboratories Company Information
  69. 8.12.2 Alkem Laboratories Business Overview
  70. 8.12.3 Alkem Laboratories Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Alkem Laboratories Rasagiline Tablet Product Portfolio
  72. 8.12.5 Alkem Laboratories Recent Developments
  73. 8.13 Ajanta Pharma
  74. 8.13.1 Ajanta Pharma Company Information
  75. 8.13.2 Ajanta Pharma Business Overview
  76. 8.13.3 Ajanta Pharma Rasagiline Tablet Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Ajanta Pharma Rasagiline Tablet Product Portfolio
  78. 8.13.5 Ajanta Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Rasagiline Tablet Value Chain Analysis
  2. 9.1.1 Rasagiline Tablet Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Rasagiline Tablet Sales Mode & Process
  6. 9.2 Rasagiline Tablet Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Rasagiline Tablet Distributors
  9. 9.2.3 Rasagiline Tablet Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst